FIXLAYER.
PUBLIC BETA · FREE · BROWSER-LOCAL

Your billing works.
Does your product agree?

Find inconsistencies between what your customers used, what your systems recorded, and what you billed — with evidence you can inspect. Start with synthetic data, without an account.

✓ No API keys✓ No data uploads to a server✓ Read-only diagnostics✓ No account required
Evidence, not guesswork

See exactly where the records diverge.

The beta compares separate records and returns reproducible findings with their supporting input data. Each result tells you what to check before taking action.

It does not issue refunds, update credit balances or change customer access. It does not certify financial losses.

Try with an example →
● FIXLAYER / Example diagnostic
4Example findings
3Usage events
2Invoices
Duplicate metering eventReview
Accepted but unmeteredReview
Invoice amount mismatchReview

Illustration using synthetic data. No recovered revenue is asserted.

One click to first insight

Two audits, one independent perspective.

01 / CSV AUDIT

Billing ↔ Product access

Compare billing and entitlement snapshots. Flag missing access, inconsistent plans and ambiguous time windows.

02 / JSON AUDIT

Usage → Metering → Invoice

Compare source consumption, ingestion acknowledgments, metering records and simplified invoice amounts. Distinguish pending events from older missing events.

What is available today

Small enough to trust. Clear about limits.

CHECK

Deterministic checks

Input records and explicit rules, not AI guesses, determine findings.

EXPLAIN

Traceable evidence

Each issue includes source records and suggested review steps.

EXPORT

Portable results

Download JSON evidence; the CSV access audit also exports CSV and printable HTML.

What's next — not yet live

Continuous assurance is the direction.

The roadmap includes secure read-only integrations, credit grant reconciliation, richer pricing policies and scheduled monitoring. The public beta does not currently connect to Stripe, authenticate data provenance or execute financial corrections.

Diagnostic beta — not a production billing control